Monday, 25 Jan 2021
Bangla Version
Monday, 25 Jan 2021
Bangla Version
Health Desk-04 Jan,2021: Beximco Pharmaceuticals, the local partner of Serum Institute of India (SII), on Monday assured that Bangladesh will get the agreed amount of vaccine doses on time as per agreement.
Quoting a communication with Beximco, an official said the statement made by Serum Institute, India (SII)on Sunday will not impact on the deal with Bangladesh.
Bangladesh is on a priority list as a result of Prime Minister Sheikh Hasina’s diplomatic efforts, the official said.
Confusion arouse following a recent statement from Serum Institute, India (SII) whereby they stated that they will export the Oxford-Astrazeneca Covid-19 vaccine only after fulfilling their domestic demands in India.
Bangladesh has signed a deal with SII and Beximco for receiving 30 million doses of the said vaccine by the end of January or early February.
Foreign Minister Dr AK Abdul Momen is likely to talk to media at 3pm on Monday where he is likely to address the issue.
A nurse to get the first jab Wednesday
UK to quarantine visitors from nations with high COVID-19 risk
Real Madrid coach Zidane tests positive for coronavirus
Pfizer to provide 40m Covax to poor countries without profit
UN assists India's mammoth COVID-19 vaccine rollout
Global Covid cases top 97.4 million
US COVID-19 deaths exceed WWII military toll
20 lakh doses Indian gift of Oxford Covid vaccine arrives
Global Covid cases top 96 million
India to start vaccine exports from Wednesday
